Medically Supervised Weight Management

Tirzepatide for Weight Loss

A new era in clinically-proven weight management.
Fast, significant results with expert support—learn if tirzepatide is right for you.

Start Consultation FAQs & Guide

Exceptional Weight Loss

Clinical trials show average reductions up to 21% body weight in one year—unmatched by most available alternatives.

Dual Hormone Action

Tirzepatide uniquely targets both GLP-1 and GIP receptors, curbing appetite and improving metabolic health far beyond traditional options.

Sustained Results

Weight is kept off with ongoing therapy and professional monitoring, not just lost rapidly and regained soon after.

Medical Oversight

Expert clinicians manage your dose, progress, and side effects—ensuring safety and maximizing your long-term success.

What Is Tirzepatide?

Tirzepatide is a groundbreaking medication that represents a major advance in the science of weight management. Approved by the FDA for chronic weight control in adults with obesity or overweight and at least one weight-related condition, tirzepatide works by mimicking two natural hormones (GLP-1 and GIP) that regulate appetite and blood sugar.

Unlike earlier GLP-1 medications, tirzepatide harnesses dual hormonal pathways to produce both dramatic weight loss and improvements in metabolic health. These dual actions make it a powerful tool for individuals who have struggled with weight despite diet, exercise, or even other prescription options.

How Tirzepatide Works in the Body

Most people are familiar with willpower-based weight loss—cutting calories, tracking steps, exercising self-restraint. Medications like tirzepatide provide a fundamentally different approach. Injected once weekly, it signals the brain and gut that you’re full sooner, reduces cravings, and slows gastric emptying, which helps stabilize blood sugar and reduce hunger spikes.

Because it stimulates both GLP-1 and GIP receptors, tirzepatide suppresses appetite more robustly than single-hormone treatments. Many individuals report a natural, effortless reduction in portions and snacking, with less discomfort or fatigue compared to older medications.

  • Appetite is diminished, making healthy choices easier
  • Blood sugar levels are more stable throughout the day
  • Weight loss is steady and significant, without extreme restriction

Real-World Benefits: Beyond the Scale

In the pivotal SURMOUNT clinical trials, patients taking tirzepatide lost on average 15-21% of their starting body weight over 72 weeks. That’s 35–50 pounds for someone starting at 240 pounds—not just temporary water loss, but true fat reduction. These results outpace even the most successful lifestyle interventions, and exceed what’s typical for other GLP-1 agonists.

Most participants also saw meaningful improvements in blood pressure, cholesterol, and markers of insulin resistance. For people with prediabetes or metabolic syndrome, tirzepatide’s benefits extend well beyond weight, helping to reduce future health risks.

  • Less joint pain and improved physical mobility
  • Better energy and focus for daily activities
  • Enhanced self-confidence and motivation to maintain progress

Tirzepatide vs Other Prescription Weight Loss Options

For years, weight management prescriptions largely relied on appetite suppressants or older GLP-1 drugs such as Wegovy or Ozempic. Tirzepatide’s dual-action mechanism delivers not only greater average weight loss but also improved tolerability for many people. Compared to semaglutide, trial data shows an additional 5–8% reduction in body weight.

That said, medication is never “one size fits all.” Factors like pre-existing medical conditions, insurance coverage, and individual goals all influence whether tirzepatide is appropriate—or whether another obesity medication may be better suited.

Eligibility: Who Can Benefit from Tirzepatide?

Not everyone qualifies for tirzepatide. The medication is typically prescribed to adults with:

  • A body mass index (BMI) of 30 or higher (obesity); or
  • BMI of 27+ with conditions like type 2 diabetes, hypertension, or sleep apnea

A licensed healthcare provider will conduct a detailed health evaluation—including your medical history, current medications, and recent lab work—before prescribing tirzepatide. This personalized approach ensures both safety and effectiveness.

Safety & Side Effects: What to Expect

Like all prescription medications, tirzepatide does carry potential risks. The most common side effects are gastrointestinal and tend to improve over time:

  • Nausea and mild stomach upset
  • Diarrhea or constipation
  • Occasionally, decreased appetite or taste changes

Serious complications are rare, but anyone experiencing severe abdominal pain, persistent vomiting, or signs of gallbladder inflammation should contact their provider immediately. Ongoing medical monitoring is essential for adjusting the dose and catching uncommon issues early.

How to Start: The Tirzepatide Experience

Starting tirzepatide involves a stepwise approach: you’ll begin on a low dose, increasing gradually as your body adjusts. This titration helps minimize side effects and sets you up for long-term adherence. Most people inject once weekly, at home, after training from their care team.

  1. Consult with a certified provider to confirm eligibility
  2. Complete baseline labs and medical evaluation
  3. Begin at the initial dose, with follow-ups every 2–4 weeks
  4. Monitor weight, symptoms, and progress with your care team

Many patients find the support of a structured program—regular check-ins, nutrition guidance, and progress tracking—dramatically improves outcomes versus going it alone. For more information, explore all our weight loss medications or begin your consult today.

Results That Matter
21%
Avg. Weight Loss
in Clinical Trials
3.2M+
People Started GLP-1
Therapy (2024)
96%
Patient Retention
at 12 Months
2x
Improvement in Blood
Sugar Control vs. Standard Care
Questions & Answers

Tirzepatide: Frequently Asked Questions

Tirzepatide is an injectable prescription medication originally developed for type 2 diabetes that is now FDA-approved for chronic weight management. It mimics the natural hormones GLP-1 and GIP, helping to regulate blood sugar, reduce appetite, and increase feelings of fullness, resulting in significant weight loss for many patients.
In clinical trials, tirzepatide has demonstrated greater average weight loss than most current GLP-1 medications, including semaglutide. While individual results vary, studies have shown up to 21% body weight reduction, making it one of the most effective injectable options now available.
Tirzepatide is typically prescribed for adults with a BMI of 30 or higher, or 27+ with weight-related health conditions. Eligibility is determined by a licensed healthcare provider based on your medical history, medications, and overall health profile.
Common side effects include mild-to-moderate nausea, vomiting, diarrhea, constipation, and decreased appetite, especially when starting or titrating the dose. Most symptoms improve over time. Serious side effects are rare but may include pancreatitis or gallbladder problems.
Tirzepatide must be prescribed and monitored by a healthcare provider. Treatment usually begins at a low dose, gradually increasing to minimize side effects. Regular follow-up appointments and progress check-ins are essential for safety, side effect management, and achieving optimal results.

Ready to Take Control?

Join thousands who have achieved real weight loss with expert medical support. Act now—appointments fill quickly.

Find My Program